Tim Heffernan retweeted
Timothy Heffernan, Lilli Petruzzelli, and James Christensen, who joined virtually, discussed the academic, industry, and biotech perspectives on drug discovery during an #AACRdrugdev26 plenary session chaired by William Pao. @timheff5
Tim Heffernan retweeted
That's a wrap on #ASCO26.
This year, UT MD Anderson shared nearly 130 abstracts, including 34 podium presentations, advancing research and bringing new insights to cancer care. Thank you to everyone who connected with us at our booth, attended presentations and joined the conversation throughout the meeting.
@ASCO #EndCancer
ALT UT MD Anderson booth
ALT UT MD Anderson faculty at the booth.
ALT UT MD Anderson team after Dr. Giordano's award presentation.
ALT Dr. Scott Kopetz presenting.
Tim Heffernan retweeted
Excited to share our collaborative paper with @Aiims1742 @timheff5 @rkalluriMDPhD @Boehringer @IamLinghua @cjder23 and @broadinstitute PRISM lab describing the efficacy of BI-2493 (panKRASi) in preclinical PDAC models.
🧵1/4
Congratulations to @mcandrews_kate @MDAndersonNews for @ScienceTM paper, a collaboration @Boehringer @timheff5 @rkalluriMDPhD
An allele-agnostic mutant-KRAS inhibitor suppresses tumor maintenance signals and reprograms tumor immunity in #PancreaticCancer
science.org/doi/10.1126/scit…
@LabGenovese “EMT favours the emergence of genomic-unstable, highly fit tumour cells, which strongly supports the concept of cell-state-restricted patterns of evolution” @MDAndersonNews nature.com/articles/s41586-0…
Tim Heffernan retweeted
It was a busy day at the MD Anderson booth today at #SITC24. Check out who will be in the booth tomorrow at MDAnderson.org/SITC and stop by to chat with our experts. @SITC24 #EndCancer
ALT A group of people stand in the booth smiling and hold coffee cups
ALT Three people stand in a circle, laughing
Tim Heffernan retweeted
The Boston Celtics are NBA Champions!
The NBA team with the most championship trophies!
Tim Heffernan retweeted
Thank you to everyone who stopped by our booth at #AACR24 to discuss the latest cancer research advances. We hope to see you all again next year. #EndCancer
ALT Photos of MD Anderson researchers at AACR24
ALT Photos of MD Anderson researchers at AACR24
ALT Photos of MD Anderson researchers at AACR24
ALT Photos of MD Anderson researchers at AACR24
Tim Heffernan retweeted
Another KRAS inhibitor enters the clinic. This is @Boehringer orally bioavailable multiKRASi BI-3706674 currently undergoing dose escalation in WT KRAS amplified upper GI cancers.
clinicaltrials.gov/study/NCT…
Cc: @DavidHongMD @DrShubhamPant @timheff5 @norbertkraut1 @gerlach_d
Tim Heffernan retweeted
Team @MDAndersonNews has landed at Kiawah for the @break_cancer summit. Ready for three days of #RadicalCollaboration!
#BTCsummit2023
@RonDePinho @DraettaG @timheff5 @claytonboldt @karenluMD @IamLinghua @mcandrews_kate @ca_chung @boehmjesse @kebmchugh
Tim Heffernan retweeted
We empower patients with #rarecancers to donate their tissue to research happening at leading institutions + labs through our platform Pattern.org.
Some of our partners are @MDAndersonNews, @kochinstitute & @DanaFarber, @broadinstitute, @BrighamWomens, @ATLPedsHemOnc
Tim Heffernan retweeted
Huge congratulations this morning to @rkalluriMDPhD & especially two @KalluriLab MVPs - Kate McAndrews @krishnaniyer199 - for their double header this morning on KRAS inhibition in #PancreaticCancer!
The 1st in @Dev_Cell and the 2nd in @Cancer_Cell 🧵 below:
Tim Heffernan retweeted
Want to accelerate your research with industry collaboration?
Learn how from our Jean Gilbert, Dr. Tim Heffernan and Dr. Timothy Yap on June 4 from 9 – 9:30 a.m. in booth 14030 at #ASCO23. @jeangilbert_ @TimHeff5 @ASCO #EndCancer [2/8]
ALT Meet the Experts Accelerating research with industry collaborations Booth 14030
Tim Heffernan retweeted
In an interview w/ @endpts, our CEO @mike_nally & @timheff5 provide their perspectives on Generate’s newest collaboration with @MDAndersonNews. Together, we are bringing #GenerativeAI into the field of oncology. Read the full article by @RLCscienceboss:
Generate Biomedicines @generate_biomed and MD Anderson @MDAndersonNews collaborate on cancer drugs made with generative AI, read more in my story for @endpts endpts.com/generate-biomedic…
@MDAndersonNews and the @broadinstitute will host the 2023 Rare Cancer Research Symposium on May 4th in Houston, TX. The event will feature a keynote address from @kaelin_lab and presentations from leaders across the rare cancer field. Learn more: lnkd.in/g4hU34tA
The agenda will feature @CKadoch, @GhayasIssa, @CMullighan, @roelverhaak, @LabGenovese, @notSoJunkDNA, @corrie_painter, @MarkLaabs, @MoonyTseng, @VivekSubbiah, and others. Join us in Houston on May 4th. @gdraetta
Tim Heffernan retweeted
“The ability to build an expansive catalog of disease models opens new avenues to advance impactful medicines,” says our Dr. Timothy Heffernan of a collaboration with @Xilis_Inc. Learn about it here: fal.cn/3w9Ut @timheff5 @skopetz @lab_rezvani #EndCancer
Tim Heffernan retweeted
Stellar team work between different groups at @MDAndersonNews and the @break_cancer killing ras group there @timheff5 @Aiims1742 @KalluriLab #endcancer
🚨🚨NEW preprint by @MDAndersonNews #PancreaticCancer team led by @rkalluriMDPhD @KalluriLab & supported by @break_cancer & @lustgartenfdn:
@Mirati MRTX1133 reprograms the tumor microenvironment & in combination with #Immunotherapy reverses ADVANCED cancer
biorxiv.org/content/10.1101/…
Tim Heffernan retweeted
MD Anderson is collaborating with @Xilis_Inc to support preclinical research to accelerate the development of novel cancer therapies. Learn about it here: fal.cn/3vT62 @timheff5 @skopetz @lab_rezvani #Research #EndCancer